Lumos Labs Case Signals to Health Software Industry an Intention by the FTC to Police Industry’s Advertising Claims

The Federal Trade Commission’s pursuit of Lumos Labs over advertising claims made about its Luminosity brain training software programs has sent a clear cautionary signal to the health software industry that the FTC intends to exercise regulatory authority over advertising in the space to monitor companies’ health-related advertising claims for deceptive advertising issues. The FTC…

Read More